Earnings Date
Nov 6
EPS
$-1.330
Quarterly Revenue
$8K
Annual Revenue (as of Sep 30)
$8K
Earnings History
Analyze the earnings history of Keros Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/01/2024 | PM | KROS | Q4 | -$1.09 | — | — | — | $0.00 | — | — | — | Get Alert |
| 11/06/2023 | AM | KROS | Q3 | -$0.92 | -$1.35 | -$1.33 | 1.48% | $0.00 | — | $8.00K | — | Get Alert |
| 08/07/2023 | AM | KROS | Q2 | -$1.13 | -$1.34 | -$1.27 | 5.22% | $0.00 | $220.00K | $0.00 | -100.00% | Get Alert |
| 05/04/2023 | PM | KROS | Q1 | -$1.01 | -$1.12 | -$1.26 | -12.50% | $0.00 | $220.00K | $0.00 | -100.00% | Get Alert |
| 03/03/2023 | PM | KROS | Q4 | -$0.30 | -$1.10 | -$1.09 | 0.91% | $20.00M | $860.00K | $0.00 | -100.00% | Get Alert |
| 11/03/2022 | AM | KROS | Q3 | -$0.87 | -$1.23 | -$0.92 | 25.20% | $0.00 | — | $0.00 | — | Get Alert |
| 08/04/2022 | PM | KROS | Q2 | -$0.67 | -$1.06 | -$1.13 | -6.60% | $100.00K | — | $0.00 | — | Get Alert |
| 05/05/2022 | PM | KROS | Q1 | -$0.68 | -$0.86 | -$1.01 | -17.44% | $0.00 | — | $0.00 | — | Get Alert |
| 03/09/2022 | PM | KROS | Q4 | -$0.49 | -$0.94 | -$0.30 | 68.09% | $0.00 | — | $20.00M | — | Get Alert |
| 11/04/2021 | PM | KROS | Q3 | -$0.60 | — | -$0.87 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/05/2021 | PM | KROS | Q2 | -$0.62 | -$0.65 | -$0.67 | -3.08% | $0.00 | — | $100.00K | — | Get Alert |
| 05/06/2021 | PM | KROS | Q1 | -$5.11 | -$0.58 | -$0.68 | -17.24% | $0.00 | — | $0.00 | — | Get Alert |
| 03/25/2021 | AM | KROS | Q4 | -$1.32 | — | -$0.49 | — | — | — | $0.00 | — | Get Alert |
| 11/10/2020 | PM | KROS | Q3 | -$1.71 | — | -$0.60 | — | — | — | $0.00 | — | Get Alert |
| 08/13/2020 | AM | KROS | Q2 | -$1.44 | — | -$0.62 | — | — | — | $0.00 | — | Get Alert |
| 05/22/2020 | AM | KROS | Q1 | — | — | -$5.11 | — | — | — | $0.00 | — | Get Alert |
When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?
Keros Therapeutics (KROS) is scheduled to report earnings on March 1, 2024. The last reported earnings were for reported on November 6, 2023 for Q3.
What were the latest earnings per share (EPS) for Keros Therapeutics (NASDAQ:KROS)?
The Actual EPS was $-1.33, which beat the estimate of $-1.35.
What were Keros Therapeutics’s (NASDAQ:KROS) revenues?
The Actual Revenue was $8K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.